Logo image of SERI.MI

SERI INDUSTRIAL SPA (SERI.MI) Stock Fundamental Analysis

BIT:SERI - Euronext Milan - IT0005283640 - Common Stock - Currency: EUR

2.175  -0.07 (-3.12%)

Fundamental Rating

3

Overall SERI gets a fundamental rating of 3 out of 10. We evaluated SERI against 61 industry peers in the Chemicals industry. Both the profitability and financial health of SERI have multiple concerns. SERI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

SERI had negative earnings in the past year.
SERI had a positive operating cash flow in the past year.
In the past 5 years SERI reported 4 times negative net income.
SERI had a positive operating cash flow in 4 of the past 5 years.
SERI.MI Yearly Net Income VS EBIT VS OCF VS FCFSERI.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M -100M

1.2 Ratios

SERI's Return On Assets of -2.46% is in line compared to the rest of the industry. SERI outperforms 40.98% of its industry peers.
SERI has a Return On Equity of -8.71%. This is in the lower half of the industry: SERI underperforms 62.30% of its industry peers.
Industry RankSector Rank
ROA -2.46%
ROE -8.71%
ROIC N/A
ROA(3y)-1.44%
ROA(5y)-1.02%
ROE(3y)-4.5%
ROE(5y)-3.16%
ROIC(3y)N/A
ROIC(5y)N/A
SERI.MI Yearly ROA, ROE, ROICSERI.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40 -60

1.3 Margins

With a decent Gross Margin value of 50.22%, SERI is doing good in the industry, outperforming 77.05% of the companies in the same industry.
In the last couple of years the Gross Margin of SERI has grown nicely.
The Profit Margin and Operating Margin are not available for SERI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.08%
GM growth 5Y2.34%
SERI.MI Yearly Profit, Operating, Gross MarginsSERI.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600 -800

More info and screens

3

2. Health

2.1 Basic Checks

SERI does not have a ROIC to compare to the WACC, probably because it is not profitable.
SERI has more shares outstanding than it did 1 year ago.
SERI has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SERI has an improved debt to assets ratio.
SERI.MI Yearly Shares OutstandingSERI.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
SERI.MI Yearly Total Debt VS Total AssetsSERI.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

SERI has an Altman-Z score of 0.67. This is a bad value and indicates that SERI is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.67, SERI is not doing good in the industry: 78.69% of the companies in the same industry are doing better.
The Debt to FCF ratio of SERI is 2.53, which is a good value as it means it would take SERI, 2.53 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.53, SERI belongs to the top of the industry, outperforming 91.80% of the companies in the same industry.
SERI has a Debt/Equity ratio of 0.58. This is a neutral value indicating SERI is somewhat dependend on debt financing.
The Debt to Equity ratio of SERI (0.58) is worse than 60.66% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 2.53
Altman-Z 0.67
ROIC/WACCN/A
WACC7.86%
SERI.MI Yearly LT Debt VS Equity VS FCFSERI.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M -100M

2.3 Liquidity

SERI has a Current Ratio of 1.39. This is a normal value and indicates that SERI is financially healthy and should not expect problems in meeting its short term obligations.
SERI's Current ratio of 1.39 is on the low side compared to the rest of the industry. SERI is outperformed by 62.30% of its industry peers.
A Quick Ratio of 0.85 indicates that SERI may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.85, SERI is doing worse than 68.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 0.85
SERI.MI Yearly Current Assets VS Current LiabilitesSERI.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

5

3. Growth

3.1 Past

SERI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.22%, which is quite impressive.
Looking at the last year, SERI shows a very negative growth in Revenue. The Revenue has decreased by -38.31% in the last year.
Measured over the past years, SERI shows a small growth in Revenue. The Revenue has been growing by 7.16% on average per year.
EPS 1Y (TTM)29.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.29%
Revenue 1Y (TTM)-38.31%
Revenue growth 3Y9.82%
Revenue growth 5Y7.16%
Sales Q2Q%-9.79%

3.2 Future

The Earnings Per Share is expected to grow by 18.89% on average over the next years. This is quite good.
The Revenue is expected to grow by 36.04% on average over the next years. This is a very strong growth
EPS Next Y-89.36%
EPS Next 2Y-14.18%
EPS Next 3Y18.89%
EPS Next 5YN/A
Revenue Next Year5.44%
Revenue Next 2Y22.95%
Revenue Next 3Y36.04%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SERI.MI Yearly Revenue VS EstimatesSERI.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
SERI.MI Yearly EPS VS EstimatesSERI.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -0.1 -0.2 -0.3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

SERI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SERI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SERI.MI Price Earnings VS Forward Price EarningsSERI.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SERI is valued a bit cheaper than 63.93% of the companies in the same industry.
96.72% of the companies in the same industry are more expensive than SERI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 2.43
EV/EBITDA 9.15
SERI.MI Per share dataSERI.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

A more expensive valuation may be justified as SERI's earnings are expected to grow with 18.89% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-14.18%
EPS Next 3Y18.89%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SERI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SERI INDUSTRIAL SPA

BIT:SERI (5/5/2025, 4:55:04 PM)

2.175

-0.07 (-3.12%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners14.71%
Inst Owner ChangeN/A
Ins Owners56.47%
Ins Owner ChangeN/A
Market Cap117.41M
Analysts80
Price Target5.41 (148.74%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.74
P/FCF 2.43
P/OCF 1.37
P/B 0.94
P/tB 3.42
EV/EBITDA 9.15
EPS(TTM)-0.17
EYN/A
EPS(NY)-0.25
Fwd EYN/A
FCF(TTM)0.89
FCFY41.12%
OCF(TTM)1.59
OCFY73.25%
SpS2.93
BVpS2.3
TBVpS0.64
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.46%
ROE -8.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.22%
FCFM 30.56%
ROA(3y)-1.44%
ROA(5y)-1.02%
ROE(3y)-4.5%
ROE(5y)-3.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.08%
GM growth 5Y2.34%
F-Score6
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 2.53
Debt/EBITDA 3.57
Cap/Depr 130.41%
Cap/Sales 23.87%
Interest Coverage N/A
Cash Conversion 425.53%
Profit Quality N/A
Current Ratio 1.39
Quick Ratio 0.85
Altman-Z 0.67
F-Score6
WACC7.86%
ROIC/WACCN/A
Cap/Depr(3y)99.27%
Cap/Depr(5y)161.41%
Cap/Sales(3y)13.79%
Cap/Sales(5y)17.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.29%
EPS Next Y-89.36%
EPS Next 2Y-14.18%
EPS Next 3Y18.89%
EPS Next 5YN/A
Revenue 1Y (TTM)-38.31%
Revenue growth 3Y9.82%
Revenue growth 5Y7.16%
Sales Q2Q%-9.79%
Revenue Next Year5.44%
Revenue Next 2Y22.95%
Revenue Next 3Y36.04%
Revenue Next 5YN/A
EBIT growth 1Y21.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year242.99%
EBIT Next 3Y130.6%
EBIT Next 5Y55.53%
FCF growth 1Y303.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1380.45%
OCF growth 3Y357.92%
OCF growth 5Y56.2%